Literature DB >> 25450505

Alpha B- and βA3-crystallins containing d-aspartic acids exist in a monomeric state.

Hiroaki Sakaue1, Takumi Takata2, Norihiko Fujii3, Hiroshi Sasaki4, Noriko Fujii5.   

Abstract

Crystallin stability and subunit-subunit interaction are essential for eye lens transparency. There are three types of crystallins in lens, designated as α-, β-, and γ-crystallins. Alpha-crystallin is a hetero-polymer of about 800kDa, consisting of 35-40 subunits of two different αA- and αB-subunits, each of 20kDa. The β/γ-crystallin superfamily comprises oligomeric β-crystallin (2-6 subunits) and monomeric γ-crystallin. Since lens proteins have very long half-lives, they undergo numerous post-translational modifications including racemization, isomerization, deamidation, oxidation, glycation, and truncation, which may decrease crystallin solubility and ultimately cause cataract formation. Racemization and isomerization of aspartyl (Asp) residues have been detected only in polymeric α- and oligomeric β-crystallin, while the situation in monomeric γ-crystallin has not been studied. Here, we investigated the racemization and isomerization of Asp in the γ-crystallin fraction of elderly donors. The results show that Asp residues of γS-, γD- and γC-crystallins were not racemized and isomerized. However, strikingly, we found that a portion of αB-crystallin and βA3-crystallin moved to the lower molecular weight fraction which is the same size of γ-crystallin. In those fractions, Asp-96 of αB-crystallin and Asp-37 of βA3-crystallin were highly inverted, which do not occur in the native lens higher molecular weight fraction. Our results indicate the possibility that the inversion of Asp residues may induce dissociation of αB- and βA3-crystallins from the polymeric and oligomeric states. This is the first report that stereoinversion of amino acids disturbs lens protein assembly in aged human lens.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Monomerization; Racemization; d-Asp; αB-crystallin; βA3-crystallin

Mesh:

Substances:

Year:  2014        PMID: 25450505     DOI: 10.1016/j.bbapap.2014.10.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Deamidation of Human γS-Crystallin Increases Attractive Protein Interactions: Implications for Cataract.

Authors:  Ajay Pande; Natalya Mokhor; Jayanti Pande
Journal:  Biochemistry       Date:  2015-07-29       Impact factor: 3.162

2.  D-β-aspartyl residue exhibiting uncommon high resistance to spontaneous peptide bond cleavage.

Authors:  Kenzo Aki; Emiko Okamura
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

3.  Different alpha crystallin expression in human age-related and congenital cataract lens epithelium.

Authors:  Jing Yang; Sheng Zhou; Minfei Guo; Yuting Li; Jianjun Gu
Journal:  BMC Ophthalmol       Date:  2016-05-28       Impact factor: 2.209

4.  Identification of Sequence Similarities among Isomerization Hotspots in Crystallin Proteins.

Authors:  Yana A Lyon; Georgette M Sabbah; Ryan R Julian
Journal:  J Proteome Res       Date:  2017-03-07       Impact factor: 4.466

5.  Effect of Ocular Hypertension on D-β-Aspartic Acid-Containing Proteins in the Retinas of Rats.

Authors:  Takashi Kanamoto; Takashi Tachibana; Yasushi Kitaoka; Toshio Hisatomi; Yasuhiro Ikeda; Yusuke Murakami; Kei Tobiume; Ryo Asaoka; Yoshiaki Kiuchi
Journal:  J Ophthalmol       Date:  2019-05-21       Impact factor: 1.909

6.  Mechanism of Action of VP1-001 in cryAB(R120G)-Associated and Age-Related Cataracts.

Authors:  Kathleen S Molnar; Bryan M Dunyak; Bonnie Su; Yevgeniy Izrayelit; Brittney McGlasson-Naumann; Paul D Hamilton; Mingxing Qian; Douglas F Covey; Jason E Gestwicki; Leah N Makley; Usha P Andley
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-08-01       Impact factor: 4.799

Review 7.  D-Amino Acids and D-Amino Acid-Containing Peptides: Potential Disease Biomarkers and Therapeutic Targets?

Authors:  Mohamed Abdulbagi; Liya Wang; Orwa Siddig; Bin Di; Bo Li
Journal:  Biomolecules       Date:  2021-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.